USFDA flags heart inflammation risk after taking Novavax COVID vaccine Ruchika Sharma4 Jun 2022 3:09 PM ISTThe FDA said it had requested Novavax to flag myocarditis and another kind of heart inflammation as an "important identified risk" in its materials.
Walvax Biotechnology COVID booster stronger against Omicron than Sinovac shot, shows trial data Ruchika Sharma4 Jun 2022 10:00 AM ISTBeijing: A COVID-19 vaccine candidate from China's Walvax Biotechnology using mRNA technology triggered a stronger antibody response against the...
Women more likely to develop skin rash from Moderna COVID vaccine, says Japanese study Roshni Dhar3 Jun 2022 6:00 PM ISTA study in Japan found that women were significantly more likely than men to develop rash-like side effects after a first dose of Moderna Inc's...
Health Bulletin 3/June/2022 Roshni Dhar3 Jun 2022 5:29 PM ISTHere are the top health stories of the day:Use khadi, wear khadi: NMC advises doctors, medical colleges, hospitalStressing the need to encourage the...
Study says Pfizer COVID drug Paxlovid reduces COVID risk in seniors regardless of vaccine status Ruchika Sharma3 Jun 2022 1:17 PM ISTPfizer's clinical trial tested Paxlovid in unvaccinated people who had risk factors for serious disease and found that the two-drug treatment cut the...
Pfizer-BioNTech seeks USFDA authorisation for COVID vaccine for kids under 5 years Ruchika Sharma3 Jun 2022 11:30 AM ISTNo COVID-19 shot is yet approved for children in that age group in most parts of the world.
Women more likely to develop skin rash from Moderna COVID vaccine: Japanese study Ruchika Sharma2 Jun 2022 4:13 PM ISTThe symptoms were mild and not considered a contraindication of the mRNA-based vaccine, according to the June 1 report in the Journal of the American...
Pfizer-BioNTech COVID booster authorized in Canada for 16, 17-year-olds Ruchika Sharma2 Jun 2022 10:00 AM ISTThe agency said potential risks of inflammatory heart conditions, myocarditis or pericarditis, have been included in the shot's label.
Moderna gets back Spikevax marketing rights in Japan Ruchika Sharma1 Jun 2022 10:00 AM ISTIn Japan, Spikevax is indicated for the prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2.
445 new COVID cases reported in Delhi while Argentina confirms its 1st case of monkey pox Isra Zaman28 May 2022 5:41 PM ISTIn the past 24 hours, Delhi reports 445 new cases, 0 deaths, and 479 recoveries and has 1,627 active cases with a positivity rate of 2.04 percent. ...
Health Bulletin 28/May/2022 Isra Zaman28 May 2022 5:07 PM ISTHere are the top health stories for the day:NMC releases draft registered medical practitioner professional conduct regulations 2022Addressing various...
Bharat Biotech Covaxin to be recognized in Germany for travel from June 1 Ruchika Sharma28 May 2022 9:30 AM ISTCovaxin is a ready-to-use liquid vaccine, stored at 2-8 degrees Celsius, with 12 months shelf life and a multi-dose vial policy.
